Clinical efficacy of Gamma Knife® combined with transarterial chemoembolization and immunotherapy in the treatment of primary liver cancer

Table 1 Baseline characteristics of 51 patients with primary liver cancer, n (%)

Item	Case
Gender
Male	42 (82.35)
Female	9 (17.65)
Age
< 60	7 (13.73)
≥ 60	44 (86.27)
Viral infection
No	11 (21.57)
HBV	34 (66.67)
HCV	4 (7.84)
HBV + HCV	2 (3.92)
Child-Pugh grade
A	45 (88.24)
B	6 (11.76)
BCLC
B	11 (21.57)
C	40 (78.43)
Tumor number
1	20 (39.22)
≥ 2	31 (60.78)
Tumor diameter
< 5 cm	19 (37.25)
≥ 5 cm	32 (62.75)

HBV: Hepatitis B virus; HCV: Hepatitis C virus; BCLC: Barcelona clinic liver cancer.